Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOTIC: Lower Maintenance Dose Ticagrelor in ACS
NCT04060914Phase 4Unknown
- Sponsor
- Beijing An Zhen Hospital
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Beijing An Zhen Hospital. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04060914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04060914.